Asian Granito India DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.99×0.86×2.63×1.33×0.77×
0.35×0.55×0.31×−3.75×1.10×
1.6%2.1%1.6%0.3%−6.5%
0.81×0.81×0.78×0.80×0.90×
1.60×1.60×1.52×1.49×1.51×
0.7%1.3%1.6%−1.6%−7.6%
1.4%1.4%2.1%−1.0%−6.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASIANTILES₹46.59

Asian Granito India Limited

· Consumer Goods
₹ CrorePeersSOMANYCERANITCOORIENTBELLEXXAROMURUDCERAREGENCERAMMcap ₹1,381 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.771.332.630.860.99
Interest Burden (Pretax/EBIT) ×1.10-3.750.310.550.35
EBIT Margin %-6.540.261.612.141.63
Asset Turnover ×0.900.800.780.810.81
Financial Leverage (Assets/Equity) ×1.511.491.521.601.60
ROE (5-step product, year-end total equity) %-7.57-1.551.571.310.73
ROE (owners' profit / average owners' equity) %-6.69-0.972.091.441.44
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.